rs4808863

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001492.6(GDF1):​c.353C>T​(p.Ala118Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 1,530,440 control chromosomes in the GnomAD database, including 111,915 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A118A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.30 ( 8791 hom., cov: 32)
Exomes 𝑓: 0.38 ( 103124 hom. )

Consequence

GDF1
NM_001492.6 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0450

Publications

23 publications found
Variant links:
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
  • progressive myoclonic epilepsy type 8
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.7131752E-5).
BP6
Variant 19-18869363-G-A is Benign according to our data. Variant chr19-18869363-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258160.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.461 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GDF1NM_001492.6 linkc.353C>T p.Ala118Val missense_variant Exon 8 of 8 ENST00000247005.8 NP_001483.3
CERS1NM_021267.5 linkc.*622C>T 3_prime_UTR_variant Exon 8 of 8 ENST00000623882.4 NP_067090.1
GDF1NM_001387438.1 linkc.353C>T p.Ala118Val missense_variant Exon 5 of 5 NP_001374367.1
CERS1NM_001387440.1 linkc.*1214C>T 3_prime_UTR_variant Exon 7 of 7 NP_001374369.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GDF1ENST00000247005.8 linkc.353C>T p.Ala118Val missense_variant Exon 8 of 8 1 NM_001492.6 ENSP00000247005.5
CERS1ENST00000623882.4 linkc.*622C>T 3_prime_UTR_variant Exon 8 of 8 1 NM_021267.5 ENSP00000485308.1

Frequencies

GnomAD3 genomes
AF:
0.304
AC:
46097
AN:
151626
Hom.:
8785
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0865
Gnomad AMI
AF:
0.308
Gnomad AMR
AF:
0.469
Gnomad ASJ
AF:
0.535
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.325
Gnomad MID
AF:
0.442
Gnomad NFE
AF:
0.396
Gnomad OTH
AF:
0.354
GnomAD2 exomes
AF:
0.372
AC:
47398
AN:
127342
AF XY:
0.362
show subpopulations
Gnomad AFR exome
AF:
0.0750
Gnomad AMR exome
AF:
0.527
Gnomad ASJ exome
AF:
0.531
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.338
Gnomad NFE exome
AF:
0.403
Gnomad OTH exome
AF:
0.421
GnomAD4 exome
AF:
0.379
AC:
522459
AN:
1378704
Hom.:
103124
Cov.:
38
AF XY:
0.375
AC XY:
255528
AN XY:
680706
show subpopulations
African (AFR)
AF:
0.0724
AC:
2240
AN:
30932
American (AMR)
AF:
0.522
AC:
18620
AN:
35670
Ashkenazi Jewish (ASJ)
AF:
0.534
AC:
13304
AN:
24910
East Asian (EAS)
AF:
0.218
AC:
7664
AN:
35150
South Asian (SAS)
AF:
0.241
AC:
19069
AN:
79070
European-Finnish (FIN)
AF:
0.347
AC:
11605
AN:
33488
Middle Eastern (MID)
AF:
0.453
AC:
1835
AN:
4054
European-Non Finnish (NFE)
AF:
0.396
AC:
427166
AN:
1077886
Other (OTH)
AF:
0.364
AC:
20956
AN:
57544
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
17080
34160
51240
68320
85400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13318
26636
39954
53272
66590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.304
AC:
46105
AN:
151736
Hom.:
8791
Cov.:
32
AF XY:
0.302
AC XY:
22425
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.0864
AC:
3584
AN:
41486
American (AMR)
AF:
0.470
AC:
7173
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.535
AC:
1849
AN:
3454
East Asian (EAS)
AF:
0.181
AC:
926
AN:
5126
South Asian (SAS)
AF:
0.241
AC:
1159
AN:
4816
European-Finnish (FIN)
AF:
0.325
AC:
3416
AN:
10520
Middle Eastern (MID)
AF:
0.455
AC:
132
AN:
290
European-Non Finnish (NFE)
AF:
0.396
AC:
26850
AN:
67756
Other (OTH)
AF:
0.349
AC:
737
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1454
2909
4363
5818
7272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.380
Hom.:
15464
Bravo
AF:
0.310
TwinsUK
AF:
0.401
AC:
1486
ALSPAC
AF:
0.406
AC:
1566
ExAC
AF:
0.247
AC:
20016
Asia WGS
AF:
0.207
AC:
715
AN:
3456

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jul 29, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 22, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26656983) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.7
DANN
Uncertain
0.98
DEOGEN2
Benign
0.13
T;.
Eigen
Benign
-0.92
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.43
T;.
MetaRNN
Benign
0.000017
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.1
L;.
PhyloP100
0.045
PROVEAN
Benign
-0.52
N;.
REVEL
Benign
0.11
Sift
Benign
0.52
T;.
Sift4G
Benign
0.34
T;T
Vest4
0.0090
MPC
0.95
ClinPred
0.0025
T
GERP RS
0.93
Varity_R
0.031
gMVP
0.17
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4808863; hg19: chr19-18980172; COSMIC: COSV53200920; COSMIC: COSV53200920; API